UB Paderborn / Katalog / Suche / in CDI

Immunotherapy era in the treatment of small cell lung cancer

Medical oncology (Northwood, London, England), 2021-07, Vol.38 (7), p.86-86, Article 86

2021

Link zum Volltext

Verfügbarkeit prüfen

Ribociclib-induced hepatotoxicity

Journal of oncology pharmacy practice, 2023-07, Vol.29 (5), p.1275-1277

2023

Link zum Volltext

Verfügbarkeit prüfen

A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy

Journal of oncology pharmacy practice, 2022-07, Vol.28 (5), p.1222-1225

2022

Link zum Volltext

Verfügbarkeit prüfen

Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor

Journal of oncology pharmacy practice, 2021-12, Vol.27 (8), p.2049-2052

2021

Link zum Volltext

Verfügbarkeit prüfen

Small bowel wall edema induced by regorafenib is associated with regorafenib intolerance and shorter survival in patients with metastatic colorectal cancer: A retrospective study

Journal of oncology pharmacy practice, 2021-12, Vol.27 (8), p.1929-1935

2021

Link zum Volltext

Verfügbarkeit prüfen

The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma

Journal of oncological science, 2019-08, Vol.5 (2), p.65-69

2019

Link zum Volltext

Verfügbarkeit prüfen

The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort

Journal of oncology pharmacy practice, 2020-10, Vol.26 (7), p.1657-1666

2020

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report

Journal of oncological science, 2017-04, Vol.3 (1), p.18-21

2017

Link zum Volltext

Verfügbarkeit prüfen

The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma

Journal of cancer research and therapeutics, 2024-04, Vol.20 (3), p.909-912

2024

Link zum Volltext

Verfügbarkeit prüfen

Functional evaluation of treatment of chronic disease: Validity and reliability of the Turkish version of the Spiritual Well-Being Scale

Palliative & supportive care, 2017-12, Vol.15 (6), p.684-692

2017

Link zum Volltext

Verfügbarkeit prüfen

Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?

European journal of clinical pharmacology, 2023-04, Vol.79 (4), p.485-491

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio

Supportive care in cancer, 2023-06, Vol.31 (6), p.357-357, Article 357

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of BMI on the outcomes of CDK 4/6 inhibitor therapy in HR-positive metastatic breast cancer patients

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13010-e13010

2022

Link zum Volltext

Verfügbarkeit prüfen

VEGFR2 expressions in Th1 and CD8+ cytotoxic T lymphocytes (CTL) in colon cancer patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15535-e15535

2021

Link zum Volltext

Verfügbarkeit prüfen

Frequency of admission to prehospital emergency medical services and satisfaction level of prehospital emergency care during active chemotherapy: Frequency and satisfaction level of prehospital emergency care during chemotherapy

Medical Science and Discovery, 2022-07, Vol.9 (7), p.388-392

2022

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan-induced NASH and liver failure

Clinics and research in hepatology and gastroenterology, 2021-05, Vol.45 (3), p.101606-101606, Article 101606

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of adipose tissue distribution and metabolic activity in PET-CT images of patients with metastatic colorectal cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16038-e16038

2020

Link zum Volltext

Verfügbarkeit prüfen

The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line

European journal of clinical pharmacology, 2024-06, Vol.80 (6), p.941-947

2024

Link zum Volltext

Verfügbarkeit prüfen

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

The New England journal of medicine, 2023-08, Vol.389 (5), p.476-478

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Cancer chemotherapy and pharmacology, 2019-06, Vol.83 (6), p.1091-1097

2019

Link zum Volltext

Verfügbarkeit prüfen

Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome

Strahlentherapie und Onkologie, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Letrozole Induced Hypercalcemia in a Patient with Breast Cancer

Case reports in oncological medicine, 2014-01, Vol.2014, p.608585-4

2014

Link zum Volltext

Verfügbarkeit prüfen

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers

Journal of gastrointestinal cancer, 2023-12, Vol.54 (4), p.1316-1321

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study

Current medical research and opinion, 2024-07, Vol.40 (7), p.1137-1143

2024

Link zum Volltext

Verfügbarkeit prüfen

The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer

Journal of gastrointestinal cancer, 2022-03, Vol.53 (1), p.57-63

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Immunotherapy era in the treatment of small cell lung cancer

Ribociclib-induced hepatotoxicity

A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy

Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor

Small bowel wall edema induced by regorafenib is associated with regorafenib intolerance and shorter survival in patients with metastatic colorectal cancer: A retrospective study

The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma

The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort

Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report

The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma

Functional evaluation of treatment of chronic disease: Validity and reliability of the Turkish version of the Spiritual Well-Being Scale

Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?

Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio

The effect of BMI on the outcomes of CDK 4/6 inhibitor therapy in HR-positive metastatic breast cancer patients

VEGFR2 expressions in Th1 and CD8+ cytotoxic T lymphocytes (CTL) in colon cancer patients

Frequency of admission to prehospital emergency medical services and satisfaction level of prehospital emergency care during active chemotherapy: Frequency and satisfaction level of prehospital emergency care during chemotherapy

Irinotecan-induced NASH and liver failure

Prognostic significance of adipose tissue distribution and metabolic activity in PET-CT images of patients with metastatic colorectal cancer

The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome

Letrozole Induced Hypercalcemia in a Patient with Breast Cancer

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers

Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study

The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer

Suchergebnisse filtern